Literature DB >> 16424705

Serum vasopressin concentrations in critically ill patients.

Stefan Jochberger1, Viktoria D Mayr, Günter Luckner, Volker Wenzel, Hanno Ulmer, Stefan Schmid, Hans Knotzer, Werner Pajk, Walter Hasibeder, Barbara Friesenecker, Andreas J Mayr, Martin W Dünser.   

Abstract

OBJECTIVE: To measure arginine vasopressin (AVP) serum concentrations in critically ill patients.
DESIGN: Prospective study.
SETTING: Twelve-bed general and surgical intensive care unit in a tertiary, university teaching hospital. PATIENTS: Two-hundred-thirty-nine mixed critically ill patients and 70 healthy volunteers.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Demographic data, hemodynamic variables, vasopressor drug requirements, blood gases, AVP serum concentrations within 24 hrs after admission, multiple organ dysfunction score, and outcome were recorded. Twenty-four hours after admission, study patients had significantly higher AVP concentrations (11.9 +/- 20.6 pg/mL) than healthy controls (0.92 +/- 0.38 pg/mL; p < .001). Males had lower AVP concentrations than females (9.7 +/- 19.5 vs. 15.1 +/- 20.6 pg/mL; p = .014). Patients with hemodynamic dysfunction had higher AVP concentrations than patients without hemodynamic dysfunction (14.1 +/- 27.1 vs. 8.7 +/- 10.8 pg/mL; p = .042). Patients after cardiac surgery (n = 96) had significantly higher AVP concentrations when compared to patients admitted for other diagnoses (n = 143; p < .001). AVP concentrations were inversely correlated with length of stay in the intensive care unit (correlation coefficient, -0.222; p = .002). There was no correlation between serum AVP concentrations and the incidence of shock or specific hemodynamic parameters. Four (1.7%) of the 239 study patients met criteria for an absolute AVP deficiency (AVP, <0.83 pg/mL), and 32 (13.4%) met criteria for a relative AVP deficiency (AVP, <10 pg/mL, and mean arterial pressure, <70 mm Hg). In shock patients, relative AVP deficiency occurred in 22.2% (septic shock), 15.4% (postcardiotomy shock), and 10% (shock due to a severe systemic inflammatory response syndrome) (p = .316).
CONCLUSIONS: AVP serum concentrations 24 hrs after intensive care unit admission were significantly increased in this mixed critically ill patient population. The lack of a correlation between AVP serum concentrations and hemodynamic parameters suggests complex dysfunction of the vasopressinergic system in critical illness. Relative and absolute AVP deficiency may be infrequent entities during acute surgical critical illness, mostly remaining without significant effects on cardiovascular function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16424705     DOI: 10.1097/01.ccm.0000198528.56397.4f

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  20 in total

1.  Impact of low-dose vasopressin on trauma outcome: prospective randomized study.

Authors:  Stephen M Cohn; Janet McCarthy; Ronald M Stewart; Rachelle B Jonas; Daniel L Dent; Joel E Michalek
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

2.  Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial.

Authors:  François Lauzier; Bruno Lévy; Patrice Lamarre; Olivier Lesur
Journal:  Intensive Care Med       Date:  2006-09-22       Impact factor: 17.440

3.  The vasopressin and copeptin response in patients with vasodilatory shock after cardiac surgery: a prospective, controlled study.

Authors:  Stefan Jochberger; Corinna Velik-Salchner; Viktoria D Mayr; Günter Luckner; Volker Wenzel; Gerda Falkensammer; Hanno Ulmer; Nils Morgenthaler; Walter Hasibeder; Martin W Dünser
Journal:  Intensive Care Med       Date:  2008-09-30       Impact factor: 17.440

4.  Vasopressin in the pediatric cardiac intensive care unit: Myth or reality.

Authors:  Vishal K Singh; Rajesh Sharma; Amit Agrawal; Amit Varma
Journal:  Ann Pediatr Cardiol       Date:  2009-01

5.  Plasma copeptin levels in Chinese patients with acute ischemic stroke: a preliminary study.

Authors:  Xiang Dong; Ding-Bo Tao; Ying-Xin Wang; Hong Cao; You-Song Xu; Qiu-Yan Wang
Journal:  Neurol Sci       Date:  2013-01-25       Impact factor: 3.307

6.  Vasopressin and copeptin levels in children with sepsis and septic shock.

Authors:  Jan Hau Lee; Yoke Hwee Chan; Oi Fah Lai; Janil Puthucheary
Journal:  Intensive Care Med       Date:  2013-01-24       Impact factor: 17.440

7.  Thrombomodulin, alarmin signaling, and copeptin: cross-talk between obesity and acute ischemic stroke initiation and severity in Egyptians.

Authors:  Walaa A Keshk; Doaa H Zineldeen; Yasser A El-Heneedy; Azza A Ghali
Journal:  Neurol Sci       Date:  2018-04-10       Impact factor: 3.307

8.  Changes and effects of plasma arginine vasopressin in traumatic brain injury.

Authors:  W D Huang; J Pan; M Xu; W Su; Y Q Lu; Z J Chen; T Y Jiang; Y M Yang
Journal:  J Endocrinol Invest       Date:  2008-11       Impact factor: 4.256

9.  Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ.

Authors:  Stefan Krüger; Jana Papassotiriou; Reinhard Marre; Klaus Richter; Christian Schumann; Heike von Baum; Nils G Morgenthaler; Norbert Suttorp; Tobias Welte
Journal:  Intensive Care Med       Date:  2007-10-16       Impact factor: 17.440

10.  Serum vasopressin response in patients with intradialytic hypotension: a pilot study.

Authors:  Mira Rho; Mark A Perazella; Chirag R Parikh; Aldo J Peixoto; Ursula C Brewster
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-06       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.